Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.
BBCR Consulting has created a process called SCIO (Strategic Clinical Innovation Organization), designed to change the path from pre-clinical trial to market by creating a regulatory roadmap as part of the IND or IDE, before the clinical phase begins. SCIO’s path analysis creates innovative development pathways for your compound, maximizing efficiency in the approval process.
Our experienced and dedicated team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements. Whether for an orphan, oncology, neurology or inflammation drug development, the BBCR’s experts can provide you with a roadmap to success. Reach out to us today to learn more about how SCIO can maximize efficiency for your project.
What our clients say about us and our SCIO process:
“BBCR is an innovative designer of clinical research programs. They have the vision to see through the details of complex clinical and regulatory strategy issues, and comes up with practical and innovative solutions…”
“I would recommend BBCR for their ability to effectively build clinical development programs and provide unique support for regulatory interactions…”
Learn More About the Clients We Serve
Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process. Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.